ArticleslgStudy

science

Sciensus

Sciensus is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Sciensus rather than just read about it. In short: Sciensus Pharma Services Limited is a global life sciences business established in 1992 by founder and former chairman Charles Walsh based in London. The company supplies a wide range of specialist medications and patient support programmes for chronic, cancer and rare disease patients, with around 1,600 employees dealing with more than 230,000 patients a year.

Sciensus — main illustration
Sciensus — illustration

Key takeaways

  • Sciensus belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Sciensus to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Sciensus from memory before moving on to harder problems.

Reference excerpt

Sciensus Pharma Services Limited is a global life sciences business established in 1992 by founder and former chairman Charles Walsh based in London. The company supplies a wide range of specialist medications and patient support programmes for chronic, cancer and rare disease patients, with around 1,600 employees dealing with more than 230,000 patients a year. It works with every NHS trust in the UK. In Spring 2015, Healthcare at Home reverted to using in house logistics rather than working with a third party for all deliveries. In Autumn 2015, the company went through a full corporate rebranding, including new logos, literature, strap line and website in an attempt to re-establish the company's status in the market. The company's name was changed in 2022 from "Healthcare at Home LTD" to "Sciensus Pharma Limited", using only "Sciensus" to refer to themselves from then on. In July 2023, 1 patient died and 3 were hospitalised after being administered unlicensed versions of cabazitaxel chemotherapy provided by Sciensus. This follows reports in May 2023 of complaints of poor service and delays raised about the company, sparking a possible CQC review. This resulted in "partial suspension" of its licence by the Medicines and Healthcare products Regulatory Agency (MHRA).

History In 2013 Healthcare at Home took over almost 3,000 patients from another drug delivery company, Medco Health Solutions which pulled out of the UK market. Subsequently, the company struggled to maintain services. In March 2014 Healthcare at Home said that it was no longer accepting new ‘high risk’ patients such as those suffering from haemophilia or respiratory diseases like cystic fibrosis because it could not guarantee getting their drugs to them on time or in full. The company blamed IT issues and a ‘system failure’ relating to the firm's outsourcing of its logistics and warehousing departments. Dave Roberts, chief executive of the National Clinical Homecare Association, says there are questions about whether the rapid growth and low profit margins in the sector have contributed to the situation. ‘There’s been 20% growth in this sector year on year for several years now in terms of numbers of patients – that’s a very rapid expansion. But profits in this sector are just 2-4%. That is a poor return given the extent of capital investment needed and the governance and logistics issues. As NHS budgets have fallen, all the slack has been cut out of contracts,’ Roberts added. In its 2014 accounts Healthcare at Home, which is majority-owned by private equity firm Vitruvian Partners, reported a turnover of £1bn, with pretax profits of just £15m. The chief executive Mike Gordon stepped down in June 2014 after the revelation that seven per cent of the firm's 150,000 patients had not received their medication on time or in full during the last six months. In May 2021 it was reported that the firm had missed almost 10,000 medicine deliveries when it introduced a new IT system in October 2020 and it was put in special measures by the Care Quality Commission. The inspectors found they failed to properly investigate some health and safety incidents and "did not always learn lessons when things went wrong". On 16 October 2023, Sciensus were given 28 days to reform the firm's complaints handling process due to issues around ignoring patients concerns. The CEO of Sciencus received a written warning from the Rob Behrens, Parliamentary and Health Service Ombudsman.

References

Worked examples

Example 1 — a first encounter with Sciensus

Start with the simplest possible case. Write down what Sciensus claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Sciensus before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Sciensus ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Sciensus

In research
Sciensus appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Sciensus in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Sciensus is common in secondary-school and first-year university syllabi. It links to neighbouring topics Companies based in Staffordshire, Health care companies of England, Life sciences industry, so understanding it makes those chapters shorter.
In everyday life
Look for Sciensus outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Sciensus in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Sciensus means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Sciensus out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Sciensus in simple terms?

Sciensus Pharma Services Limited is a global life sciences business established in 1992 by founder and former chairman Charles Walsh based in London. The company supplies a wide range of specialist medications and patient support programmes for chronic, cancer and rare disease patients, with around…

Why does Sciensus matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Sciensus?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Sciensus.

Tags

  • Companies based in Staffordshire
  • Health care companies of England
  • Life sciences industry
  • Pharmaceutical companies of the United Kingdom
  • Private providers of NHS services

Keep exploring